146 related articles for article (PubMed ID: 21880232)
1. A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithm.
Feichtner F; Mader JK; Schaller R; Schaupp L; Ellmerer M; Korsatko S; Kondepati VR; Heise HM; Wilinska ME; Hovorka R; Pieber TR
J Diabetes Sci Technol; 2011 Jul; 5(4):901-5. PubMed ID: 21880232
[TBL] [Abstract][Full Text] [Related]
2. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
[TBL] [Abstract][Full Text] [Related]
3. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
4. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
[TBL] [Abstract][Full Text] [Related]
6. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
7. Use of microdialysis-based continuous glucose monitoring to drive real-time semi-closed-loop insulin infusion.
Freckmann G; Jendrike N; Pleus S; Buck H; Bousamra S; Galley P; Thukral A; Wagner R; Weinert S; Haug C
J Diabetes Sci Technol; 2014 Nov; 8(6):1074-80. PubMed ID: 25205589
[TBL] [Abstract][Full Text] [Related]
8. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.
Murphy HR; Elleri D; Allen JM; Harris J; Simmons D; Rayman G; Temple R; Dunger DB; Haidar A; Nodale M; Wilinska ME; Hovorka R
Diabetes Care; 2011 Feb; 34(2):406-11. PubMed ID: 21216859
[TBL] [Abstract][Full Text] [Related]
9. Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience.
Schmidt S; Boiroux D; Duun-Henriksen AK; Frøssing L; Skyggebjerg O; Jørgensen JB; Poulsen NK; Madsen H; Madsbad S; Nørgaard K
J Diabetes Sci Technol; 2013 Sep; 7(5):1255-64. PubMed ID: 24124952
[TBL] [Abstract][Full Text] [Related]
10. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.
Hovorka R; Allen JM; Elleri D; Chassin LJ; Harris J; Xing D; Kollman C; Hovorka T; Larsen AM; Nodale M; De Palma A; Wilinska ME; Acerini CL; Dunger DB
Lancet; 2010 Feb; 375(9716):743-51. PubMed ID: 20138357
[TBL] [Abstract][Full Text] [Related]
11. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
[TBL] [Abstract][Full Text] [Related]
12. Postprandial glycemic excursions with the use of a closed-loop platform in subjects with type 1 diabetes: a pilot study.
van Bon AC; Hermanides J; Koops R; Hoekstra JB; DeVries JH
J Diabetes Sci Technol; 2010 Jul; 4(4):923-8. PubMed ID: 20663458
[TBL] [Abstract][Full Text] [Related]
13. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
[TBL] [Abstract][Full Text] [Related]
14. Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.
Ly TT; Roy A; Grosman B; Shin J; Campbell A; Monirabbasi S; Liang B; von Eyben R; Shanmugham S; Clinton P; Buckingham BA
Diabetes Care; 2015 Jul; 38(7):1205-11. PubMed ID: 26049550
[TBL] [Abstract][Full Text] [Related]
15. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
[TBL] [Abstract][Full Text] [Related]
16. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
[TBL] [Abstract][Full Text] [Related]
17. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.
Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378
[TBL] [Abstract][Full Text] [Related]
18. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
[TBL] [Abstract][Full Text] [Related]
19. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
[TBL] [Abstract][Full Text] [Related]
20. Improving IV insulin administration in a community hospital.
Magee MC
J Vis Exp; 2012 Jun; (64):e3705. PubMed ID: 22710978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]